Loading stock data…
IH
$1.72+0.02 (+1.34%)
Market ClosedLast close May 1
iHuman Inc.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
iHuman Inc. in the Consumer Defensive sector is trading at $1.72. The stock is currently near its 52-week low of $1.55, remaining 22.7% below its 200-day moving average. Technical signals show neutral RSI of 66 and bullish MACD crossover, explaining why IH maintains its current current market pressure. The Whystock Score of 25/100 signals elevated caution as indicators diverge.
Ecosystem Influences
Overbought levels (RSI 66) — risk of consolidation or pullback
Long-term trend bearish (Price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Whystock fair value is estimated using a trailing P/E model adjusted for return on equity: Fair P/E = 18 + (ROE × 20). Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. A base P/E of 18 represents a typical market multiple, scaled upward for companies that earn high returns on equity. The result is a theoretical "normalised" price — not a price target or investment advice. Large deviations are common for high-growth or loss-making companies.
Current Price$1.72
Potential Upside
199.5%
Whystock Fair Value$5.16
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Fundamentals
iHuman Inc. provides intellectual development products to individual users, kindergartens, and distributors in the People's Republic of China and internationally. The company offers interactive and self-directed apps, including iHuman Chinese, iHuman...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$85.86M
P/E Ratio
Value territory. Trading at a high yield relative to earnings.
6.46
Beta
Defensive asset. Lower volatility than the S&P 500.
0.13
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
6.76%
Volume
Today's trading volume
13,694
Recent News
Middle Eastern Penny Stocks With Market Caps Under US$80M
The Middle Eastern stock markets have recently experienced a downturn, with Gulf shares slipping amid geopolitical tensions and reports of potential US military action against Iran. Despite these challenges, the investment landscape in the region remains diverse and offers unique opportunities for investors willing to explore beyond traditional large-cap stocks. Penny stocks, though often seen as relics from earlier market days, continue to offer potential growth at lower price points when...
Owning 72% in iHuman Inc. (NYSE:IH) means that insiders are heavily invested in the company's future
Key Insights Significant insider control over iHuman implies vested interests in company growth The largest shareholder...
A Look At The Intrinsic Value Of iHuman Inc. (NYSE:IH)
Key Insights The projected fair value for iHuman is US$2.55 based on 2 Stage Free Cash Flow to Equity With US$2.56...
Returns Are Gaining Momentum At iHuman (NYSE:IH)
To find a multi-bagger stock, what are the underlying trends we should look for in a business? In a perfect world, we'd...
iHuman Second Quarter 2025 Earnings: EPS: CN¥0.62 (vs CN¥0.47 in 2Q 2024)
iHuman ( NYSE:IH ) Second Quarter 2025 Results Key Financial Results Revenue: CN¥200.2m (down 6.9% from 2Q 2024). Net...